Since 1999, the monitoring carried out by the Emerging Trends and New Drugs (TREND) scheme of the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has made it possible to describe the population groups that are particularly dependent on psychoactive substances and to identify emerging phenomena in the field of illicit drugs and diverted medicines.
In recent years (2016-2020), an average of 180 000 people have been arrested every year by law enforcement services (police and gendarmerie) for a drug law offence in France.
Two major surveys, conducted every 4 years for the past 25 years in the adolescent population, allow for an international comparison of drug use.
Since 1999, the Emerging Trends and New Drugs (TREND) scheme of the OFDT has been monitoring emerging phenomena and developments in the field of drugs.
The Covid-19 pandemic is the origin of a health crisis that has led to more than 848 000 deaths worldwide in seven months, including more than 30 000 in France.
Monitoring gambling practices among French adults have been carried out in France since 2010, thanks to the Santé publique France (SpF) Barometer which includes a survey component focusing on gambling activities.
Estimating the amount of cannabis sales revenue is important and provides a measure of the influence of this economic sector.
Since 1999, the Emerging Trends and New Drugs (TREND) unit of the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has been monitoring emerging trends and phenomena in the field of drugs.
In France, despite legal restrictions on authorised media and content, alcohol advertising is subject to significant private investment.
The epidemic of opioid overdose deaths in the United States highlights the issue of drug-related deaths.
In 2018, two major international surveys Health Behaviour in School-aged Children (HBSC) and European School Project on Alcohol and other Drugs (ESPAD) were carried out simultaneously for the first time in France, using a unified scientific framework.
Since 1999, the OFDT has been quantifying the opinions and perceptions of the French population on drugs and related public policies through the EROPP survey (Survey on representations, opinions and perceptions regarding psychoactive drugs).
As a minority in specialised care services, French women presenting with addictions represent 23% and 18% of the public seen in specialised drug treatment centres (CSAPA) and harm reduction facilities (CAARUD) respectively.
This eight-page document provides the most relevant figures for measuring and providing a quick overview of drug-related phenomena.
Since 1999, the Emerging Trends and New Drugs (TREND) scheme of the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has been monitoring emerging trends and phenomena in the field of drugs in order to limit the time between their occurrence and their consideration by the public authorities.
Based on the findings of the 2017 Health Barometer Survey of Santé publique France (data processed by OFDT) which interviewed over 20 000 people aged 18 to 64 years, this issue of Tendances describes the changes in illicit drug use and offers an overview of cannabis supply modes.
Ten years after the emergence of new psychoactive substances (NPS), the available data reveal lower detection rates for new substances, and their use is still somewhat limited in France.
The objective of this issue is to offer a glimpse into tobacco use in Western countries, using prevalence surveys, annual data on tobacco sales and average tobacco prices.
For the ninth time since the implementation of the ESCAPAD survey, the French Monitoring Centre for Drugs and Drug Addiction (OFDT) and the Youth and National Service Directorate of the Ministry of the Armed Forces interviewed a sample of young people aged 17 years, taking part in the National Defence and Citizenship Day (JDC).
The ARAMIS study (Attitudes, perceptions, aspirations and motives surrounding the introduction to psychoactive substances) aims to explore the perceptions and motives for drug use among minors, and their trajectories for alcohol, tobacco, cannabis and/or other illicit drug use.